Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug

Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma

UK Launches First Clinical Trial Of Proton Beam Therapy For Breast Cancer To Help Patients Reduce The Risk Of Heart Problems Caused By Radiotherapy

Munich University Hospital

For Fatal Rhabdomyosarcoma, New Atr Inhibitors May Hold Therapeutic Promise

What Are The Ways To Boost Immunity In The Elderly